Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation in Locally Advanced Head and Neck Cancer
NCT00226239Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2005
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in head and neck cancer (HNC), sponsored by University of Pittsburgh. Started Oct 2005; status: completed.
02
Drugs
KL-140
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00226239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226239.